Advertisement

Abstract

To give a tumour perspective is to consider both its impact on society and its impact on the patient. The estimated incidence of carcinoma of the prostate in the United Kingdom is 5,700 new cases per year (Tate et al. 1979); it is the sixth most common malignancy overall, but the commonest cancer of the male genito-urinary tract. In the United States there are 42,000 new cases per year and this tumour is the second most common cause of cancer deaths (Klein 1979). Despite such an incidence, carcinoma of the prostate is a malignancy which lacks popular image. Just as benign prostatic hyperplasia is often relegated to ‘only an old man’s problem’, so it is that the malignant prostate has little impact on general discussions on cancer. Indeed a number of tumours with a lower incidence have more appeal and, therefore, have larger resources devoted to them.

Keywords

Prostatic Cancer Benign Prostatic Hyperplasia Radical Prostatectomy Testicular Tumour Deferred Treatment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Armenian HK, Lilienfeld AM, Diamond EL, Bross ID (1974) Relation between benign prostatic hyperplasia and cancer of the prostate. A prospective and retrospective study. Lancet 2: 15–117Google Scholar
  2. Axtell LM, Cutler SJ, Myers MH (eds) (1972) End results in cancer. Government Printing Office, Washington (Report no. 4, Department of Health, Education and Welfare; Publication no. (NIH) 73–272, National Cancer Institute)Google Scholar
  3. Bagshaw MA, Pistenma DA, Ray GR (1977) Evaluation of extended-field radiotherapy for prostate neoplasms: 1976 progress report. Cancer Treat Rep 61: 297–306PubMedGoogle Scholar
  4. Barnes RW, Hirst A, Rosenquist R (1976) Early carcinoma of the prostate: comparison of stages A and B. J Urol 115: 404–405PubMedGoogle Scholar
  5. Barnes RW, Ninan CA (1972) Carcinoma of the prostate: biopsy and conservative therapy. J Urol 108: 897–900PubMedGoogle Scholar
  6. Byar DP (1977) VACURG studies on prostatic cancer and its treatment. In: Tannenbaum M (ed) Urologie pathology: the prostate. Lea & Febiger, New York, pp 241–267Google Scholar
  7. Chisholm GD (1980) Malignancy: prostate. In: Chisholm GD (ed) Tutorials in postgraduate medicine: urology. Heinemann, London, pp 223–246Google Scholar
  8. Clark P, Houghton L (1977) Subcapsular orchidectomy for carcinoma of the prostate. Br J Urol 49: 419–425PubMedCrossRefGoogle Scholar
  9. Cutler SJ, Latourette HB (1959) A national cooperative program for the evaluation of end results in cancer. J Natl Cancer Inst 22: 633–646PubMedGoogle Scholar
  10. de Klerk DP, Coffey DS, Ewing LL, McDermott IR, Reiner WG, Robinson CH, Scott WW, Strandberg JD, Talalay P, Walsh PC, Wheaton LG, Zirkin BR (1979) Comparison of spontaneous and experimentally induced canine prostatic hyperplasia. J Clin Invest 64: 842–849CrossRefGoogle Scholar
  11. de Vere White R, Paulson DF, Glenn JF (1977) The clinical spectrum of prostate cancer. J Urol 117: 323–327Google Scholar
  12. Donohue RE, Fauver HE, Whitesel JA, Pfister RR (1979) Staging prostatic cancer: a different distribution. J Urol 122: 327–329PubMedGoogle Scholar
  13. Enstrom JE, Austin DF (1977) Interpreting cancer survival rates. Science 195: 847–851PubMedCrossRefGoogle Scholar
  14. Greenwald P, Kirmss V, Polan AK, Dick VS (1974) Cancer of the prostate among men with benign prostatic hyperplasia. J Natl Cancer Inst 53: 335–340PubMedGoogle Scholar
  15. Harisiadis L, Veenema RJ, Senyszyn JJ, Puchner PJ, Tretter P, Romas NA, Chang CH, Lattimer JK, Tannenbaum M (1978) Carcinoma of the prostate: treatment with external radiotherapy. Cancer 41: 2131–2142PubMedCrossRefGoogle Scholar
  16. Haybittle JL (1979) Results of treatment of female breast cancer in the Cambridge area 1960–71. Br J Cancer 40: 56–61PubMedCrossRefGoogle Scholar
  17. Huggins C, Hodges CV (1941) Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1: 293–297Google Scholar
  18. Jackson MA, Ahluwalia BS, Herson J (1977) Characterisation of prostatic carcinoma among blacks: a continuation report. Cancer Treat Rep 61: 167–172PubMedGoogle Scholar
  19. Jewett HJ (1975) The present status of radical prostatectomy for stages A and B prostatic cancer. Urol Clin North Am 2: 105–124PubMedGoogle Scholar
  20. Johnson DE, Hussey DH, Samuels ML (1980) Malignancy: testis. In: Chisholm GD (ed) Tutorials in postgraduate medicine: urology. Heinemann, London, pp 247–265Google Scholar
  21. Klein LA (1979) Prostatic carcinoma. N Engl J Med 300: 824–833PubMedCrossRefGoogle Scholar
  22. Lasnitski I (1976) Action of hormones on the normal prostate and prostatic tumours grown in vitro. In: Williams DI, Chisholm GD (eds) Scientific foundations of urology. Heinamann, London, pp 365–370Google Scholar
  23. Lehrer S (1978) Rectal self-examination. Am J Dig Dis 23: 572–573PubMedCrossRefGoogle Scholar
  24. Lothian Health Board (1978) Annual statistical report. Lothian Health Board, EdinburghGoogle Scholar
  25. McMillen SM, Wettlaufer JN (1976) The role of repeat transurethral biopsy in Stage A carcinoma of the prostate. J Urol 116: 759–760PubMedGoogle Scholar
  26. Morfin RF, Charles J-F, Floch HH (1979) C19O2-Steroid transformations in the human normal, hyperplastic and cancerous prostate. J Steroid Biochem 11: 599–607PubMedCrossRefGoogle Scholar
  27. Peeling WB, Griffiths GJ, Evans KT, Roberts EE (1979) Diagnosis and staging of prostatic cancer by transrectal ultrasonography. A preliminary study. Br J Urol 51: 565–569PubMedCrossRefGoogle Scholar
  28. Ross RK, McCurtis JW, Henderson BE, Menck HR, Mack TM, Martin SP (1979) Descriptive epidemiology of testicular and prostatic cancer in Los Angeles. Br J Cancer 39: 284–292PubMedCrossRefGoogle Scholar
  29. Schröder FH, Belt E (1975) Carcinoma of the prostate: a study of 213 patients with stage C tumors treated by total perineal prostatectomy. J Urol 114: 257–267Google Scholar
  30. Sirett DAN, Grant JK (1978) Androgen binding in cytosols and nuclei of human benign hyperplastic prostatic tissue. J Endocrinol 77: 101–110PubMedCrossRefGoogle Scholar
  31. Stenkvist B, Westman-Naeser S, Holmquist J, Nordin B, Bengtsson E, Vegelius J, Eriksson O, Fox CH (1978) Computerized nuclear morphometry as an objective method for characterizing human cancer cell populations. Cancer Res 38: 4688–4697PubMedGoogle Scholar
  32. Tate HC, Rawlinson JB, Freedman LS (1979) Randomised comparative studies in the treatment of cancer in the United Kingdom: room for improvement? Lancet 2: 623–625PubMedCrossRefGoogle Scholar
  33. Varkarakis M, Castro JE, Azzopardi JG (1970) Prognosis of Stage 1 carcinoma of the prostate. Proc R Soc Med 63: 91–93PubMedGoogle Scholar
  34. Wajsman Z, Chu TM, Saroff J, Slack N, Murphy GP (1979) Two new, direct and specific methods of acid phosphatase determination. Urology 13: 8–11PubMedCrossRefGoogle Scholar
  35. Whitmore WF Jr (1956) Hormone therapy in prostatic cancer. Am J Med 21: 697–713PubMedCrossRefGoogle Scholar
  36. Zetterberg A, Esposti P-L (1976) Cytophotometric DNA-analysis of aspirated cells from prostatic carcinoma. Acta Cytol (Baltimore) 20: 46–57Google Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1981

Authors and Affiliations

  • G. D. Chisholm
    • 1
  1. 1.Department of Surgery (Urology)University of EdinburghGB - EdinburghUK

Personalised recommendations